<?xml version="1.0" encoding="UTF-8"?>
<p>We further assessed that TLR7 mediated astrocytic cell apoptosis with IL-6 production. In U251 cells, upon R837 treatment, cell viability was reduced (
 <xref ref-type="supplementary-material" rid="ppat.1008142.s011">S11A Fig</xref>) while LDH release was induced (
 <xref ref-type="supplementary-material" rid="ppat.1008142.s011">S11B Fig</xref>). Moreover, similar with EV71 infection, R837 stimulation induced IL-6 production (
 <xref ref-type="supplementary-material" rid="ppat.1008142.s011">S11C Fig</xref>), and the cleavage of PARP and Caspase-3 (
 <xref ref-type="supplementary-material" rid="ppat.1008142.s011">S11D Fig</xref>) in U251 cells. The data demonstrated that TLR7 agonist caused IL-6 expression and apoptosis in U251 cells (
 <italic>in vitro</italic>). In addition, we found that an appropriate concentration of IL-6 (ranged from 20 to 500 pg/ml) activated Caspase-3 cleavage in U251 cells (
 <xref ref-type="supplementary-material" rid="ppat.1008142.s011">S11E and S11F Fig</xref>), suggesting that TLR7-mediated IL-6 production triggers astrocytic cell apoptosis.
</p>
